Early Online
Securing our HIV response: The PEPFAR crisis in South Africa
DOI:
https://doi.org/10.7196/SAMJ.2025.v115i3.3216Keywords:
HIV response , PEPFAR, Funding Freeze, USAAbstract
-
References
1. Tram KH, Ratevosian J, Beyrer C. By executive order: The likely deadly consequences associated with a 90-day pause in PEPFAR funding. J Int AIDS Soc 2025;28(3):e26431. https://doi.org/10.1002/ jia2.26431
2. KFF. The US President’s Emergency Plan for AIDS Relief (PEPFAR). KFF, 2024. https://www.kff.org/ global-health-policy/fact-sheet/the-u-s-presidents-emergency-plan-for-aids-relief-pepfar (accessed 4 March 2025).
3. Ratevosian J, Millet G, Honermann B, Bennet S. PEPFAR under review: What’s at stake for PEPFAR’s future. Lancet 2025;405(10479)603-605.
4. Johnson L, Dorrington R. Thembisa version 4.7: A model for evaluating the impact of HIV/AIDS in South Africa. Thembisa Project, 2024. https://thembisa.org/content/downloadPage/Thembisa4_7report (accessed 4 March 2025).
5. Chigwedere P, Seage GR, Gruskin S, Lee TH, Essex M. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acqu Immune Deficiency Syndr 2008;49(4):410-415. https://doi. org/10.1097/qai.0b013e31818a6cd5
6. Gandhi AR, Bekker L-G, Paltiel AD, et al. Potential clinical and economic impacts of cutbacks in the President’s Emergency Plan for AIDS Relief Program in South Africa: A modeling analysis. Ann Intern Med 2025 (epub 11 February 2025). https://doi.org/10.7326/ANNALS-24-01104
7. Pike C, Bekker L-G. Interrogating the promise of long-acting HIV pre-exposure prophylaxis. Trends Mol Med 2023;29(2):93-98. https://doi.org/10.1016/j.molmed.2022.11.003
8. Hero. South African HIV investment case 2023. Hero, 2023. https://www.heroza.org/wp-content/ uploads/2024/01/HIV-Investment-Case-2023-Full-Report-v1.2.pdf (accessed 3 March 2025).
9. Doan TM, Shin HB, Mehta NK. To what extent were life expectancy gains in South Africa attributable to declines in HIV/AIDS mortality? Demogr Res 2022;46(18):543-555.
10. Johnson LF, Dorrington RE. Modelling the impact of HIV in South Africa’s provinces: 2024 update. Centre for Infectious Disease Epidemiology and Research, 2024. https://thembisa.org/content/ downloadPage/Province2024 (accessed 4 March 2025).
11. Pillay Y. This is how South Africa can meet its targets. Spotlight, 15 January 2024. https://www. spotlightnsp.co.za/2024/01/15/opinion-yogan-pillay-this-is-how-sa-can-meet-its-hiv-targets (accessed 4 March 2025).
12. World Health Organization. Policy Brief: Supporting re-engagement in HIV treatment services. Geneva: WHO, 2024.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 A Grimsrud, L Wilkinson, Y Raphael, S Tshabalala , A K Moses, F Hassan, K Buthelezi, K Rees, L-G Bekker
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
